Danaher Announces CFO Transition Plan

Details

McGrew, the current Executive Vice President and Chief Financial Officer, will step down from his role as CFO on February 28, 2026. He will be succeeded by Matthew E. Gugino, who currently serves as Vice President-Corporate FP&A and Group CFO for the Life Sciences Innovations businesses. The Compensation Committee of Danaher's Board of Directors has approved changes to Mr. Gugino's compensation, including an increased annual base salary, target bonus percentage, and equity award. The Company also issued a press release on July 22, 2025, detailing the anticipated CFO transition.

Items reported

Exhibits (3)

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.